Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-438 in Healthy Male Participants

NCT02123953 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Dose Finding Study

Interventions

DRUG: TAK-438
DRUG: TAK-438 Placebo

Sponsor

Takeda